A 52-year-old with recurrent CDI on vancomycin taper asks about adjunctive therapy to reduce recurrence risk. Which option is recommended for high-ris...

Question

A 52-year-old with recurrent CDI on vancomycin taper asks about adjunctive therapy to reduce recurrence risk. Which option is recommended for high-risk recurrence?

Accepted Answer

Bezlotoxumab infusion during antibiotic treatment

Answer

Probiotics

Answer

Cholestyramine

Answer

Rifaximin alone

Answer

Fecal microbiota transplantation as first episode

us-abfm MCQ (SBA): CDI Recurrence Prevention

A 52-year-old with recurrent CDI on vancomycin taper asks about adjunctive therapy to reduce recurrence risk. Which option is recommended for high-risk recurrence?